Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
QuintilesIMS
Mallinckrodt
Daiichi Sankyo
Argus Health
Harvard Business School
Cerilliant
Express Scripts

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 083040

« Back to Dashboard

NDA 083040 describes SONAZINE, which is a drug marketed by Fosun Pharma and is included in two NDAs. Additional details are available on the SONAZINE profile page.

The generic ingredient in SONAZINE is chlorpromazine hydrochloride. There are twenty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
Summary for 083040
Tradename:SONAZINE
Applicant:Fosun Pharma
Ingredient:chlorpromazine hydrochloride
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength10MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Dow
UBS
Daiichi Sankyo
Chubb
US Department of Justice
Healthtrust
Accenture
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.